The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an mRNA respiratory syncytial virus (RSV) ...

Japanese biopharma Nxera Pharma has announced two deals in a single day with partners that will commercialize its products in ...

Medicare Part D spending for 10 selected diabetes drugs in the USA totaled $35.8 billion in 2023, an increase of 364% from ...

Sino American biotech BeiGene has announced financial results and corporate updates from the fourth quarter and full year ...

Neurocrine Biosciences (Nasdaq: NBIX) has announced positive results from its Phase IV KINECT-PRO study, showing that ...

Encephalitis is a complex and often devastating condition that can leave lasting neurological damage in survivors. Despite ...

Duality Biologics, a Chinese biotech specializing in antibody-drug conjugates (ADCs), has opted not to move forward at this ...

Kallyope’s latest obesity drug trial results show modest weight-loss effects that lag behind competing therapies in the ...

The US Food and Drug Administration (FDA) has approved Odactra tablet for use in young children with house dust mite (HDM) ...

South Korean vaccine maker SK bioscience today revealed that it has received prior notification from the Pan American Health ...

Israeli drug manufacturer Teva Pharmaceutical Industries has resumed the deliveries of the scarce epilepsy drug Finlepsin ...

A pair of Republicans have reintroduced the bicameral Reciprocity Ensures Streamlined Use of Lifesaving Treatments (RESULT) ...